A roasted coffee of Coffea arabica var. Laurina a powder of which comprises from 5.0 to 10.0 mg per gram of powder (mg/g) trigonelline and from 3.0 to 8.0 mg/g mono-caffeoylquinic acids (3-caffeoylquinic acid, 4-caffeoylquinic acid and 5-caffeoylquinic acid), the invention also relating to a beverage prepared with such roasted coffee, a method for the preparation and a use of such roasted coffee for the prevention of metabolic syndrome.
